Comparison of 2 Tests to Diagnose Cognitive Dysfunctions in Alcohol Disease
- Conditions
- Alcohol Use Disorder
- Interventions
- Other: MoCA (Montreal Cognitive Assessment) testOther: BEARNI (Brief Evaluation of Alcohol Related Neuropsychological Impairment) Test
- Registration Number
- NCT04009707
- Lead Sponsor
- Centre Hospitalier Universitaire de Nīmes
- Brief Summary
The objective of this study is therefore to compare the results obtained with these two screening tests, using as gold standard the results obtained by the battery of neuropsychological reference tests.
- Detailed Description
Recently, a new screening test for cognitive disorders was specifically developed for patients with UAS: BEARNI (Brief Evaluation of Alcohol-Related Neuropsychological Impairments). Since the BEARNI is presented as the reference test, the investigators have systematically proposed it to hospitalized patients, in combination with the usual check-up. In practice, at admission, patients were therefore given two screening tests, the MoCA and the BEARNI. In the event of an anomaly in at least one of these tests, a battery of confirmatory neuropsychological tests was performed.
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 90
- patients with alcoo use desorder
- Patient cared for in the addictology department of the University Hospital of Nîmes
- refusal to use the data
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Arm && Interventions
Group Intervention Description patients with alcool use desorders BEARNI (Brief Evaluation of Alcohol Related Neuropsychological Impairment) Test Patient cared for in the addictology department of the University Hospital of Nîmes patients with alcool use desorders MoCA (Montreal Cognitive Assessment) test Patient cared for in the addictology department of the University Hospital of Nîmes
- Primary Outcome Measures
Name Time Method specificity Day 1 (only 1 time) comparison of the specificity of the 2 tests against the gold standard
sensitivity Day 1 (only 1 time) comparison of the sensitivity of the 2 tests against the gold standard
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (1)
CHU de Nîmes
🇫🇷Nîmes, France